ENSURING PATIENT ACCESS AND EFFECTIVE DRUG ENFORCEMENT ACT

Bills and resolutions

DEA: restore ability to target pharmaceutical companies distributing opioids in certain communities by implementing a probable cause standard for intervention and striking the corrective action plan option (see S. 2493), S1338 [5MR] (see H.R. 6702), H7870 [5SE]

Remarks in House

DEA: clarify definition of ‘‘imminent danger to the public health or safety’’ to restore authority to suspend a pharmaceutical distributor’s license under certain circumstances (H.R. 4079), E888 [21JN]